A 41-year-old transgender woman with HIV is evaluated in clinic for a recent positive tuberculin skin test. She is asymptomatic. A chest radiograph is obtained, and it is normal. Her current antiretroviral regimen is bictegravir-tenofovir alafenamide-emtricitabine, and she is not willing to change this regimen.
Which one of the following oral regimens is the most appropriate treatment for latent tuberculosis infection in this woman?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
October 3rd, 2024
October 3rd, 2024
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5